Published in OBGYN and Reproduction Week, July 25th, 2005
This test identifies 37 high- and low-risk human papillomavirus (HPV) genotypes, including those considered a significant risk factor for progression to cervical cancer. The test is the first HPV genotyping test kit to be registered for in vitro diagnostic use.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.